Biora Therapeutics Inc

Company Profile

Biora Therapeutics Inc had its IPO on 2020-06-19 under the ticker symbol BIOR.

The company operates in the Healthcare sector and Biotechnology industry. Biora Therapeutics Inc has a staff strength of 54 employees.

Stock update

Shares of Biora Therapeutics Inc opened at $2.95 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.7 - $2.95, and closed at $2.75.

This is a -6.78% slip from the previous day's closing price.

A total volume of 115,903 shares were traded at the close of the day’s session.

In the last one week, shares of Biora Therapeutics Inc have slipped by -7.72%.

Biora Therapeutics Inc's Key Ratios

Biora Therapeutics Inc has a market cap of $50.52 million, indicating a price to book ratio of 0 and a price to sales ratio of 53.7639.

In the last 12-months Biora Therapeutics Inc’s revenue was $200000 with a gross profit of $1.25 million and an EBITDA of $-56685000. The EBITDA ratio measures Biora Therapeutics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biora Therapeutics Inc’s operating margin was -28708.5% while its return on assets stood at -51.27% with a return of equity of 0%.

In Q1, Biora Therapeutics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 98.1%.

Biora Therapeutics Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-6.03 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biora Therapeutics Inc’s profitability.

Biora Therapeutics Inc stock is trading at a EV to sales ratio of 183.2804 and a EV to EBITDA ratio of -2.249. Its price to sales ratio in the trailing 12-months stood at 53.7639.

Biora Therapeutics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$53.24 million

Total Liabilities

$25.08 million

Operating Cash Flow

$-6000.00

Capital Expenditure

$16000

Dividend Payout Ratio

0%

Biora Therapeutics Inc ended 2024 with $53.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.24 million while shareholder equity stood at $-104998000.00.

Biora Therapeutics Inc ended 2024 with $0 in deferred long-term liabilities, $25.08 million in other current liabilities, 11000.00 in common stock, $-844284000.00 in retained earnings and $6.07 million in goodwill. Its cash balance stood at $30.46 million and cash and short-term investments were $30.46 million. The company’s total short-term debt was $890,000 while long-term debt stood at $128.19 million.

Biora Therapeutics Inc’s total current assets stands at $37.17 million while long-term investments were $6.00 million and short-term investments were $0. Its net receivables were $828000.00 compared to accounts payable of $3.42 million and inventory worth $0.

In 2024, Biora Therapeutics Inc's operating cash flow was $-6000.00 while its capital expenditure stood at $16000.

Comparatively, Biora Therapeutics Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.75

52-Week High

$28.75

52-Week Low

$1.95

Analyst Target Price

$82.5

Biora Therapeutics Inc stock is currently trading at $2.75 per share. It touched a 52-week high of $28.75 and a 52-week low of $28.75. Analysts tracking the stock have a 12-month average target price of $82.5.

Its 50-day moving average was $3.46 and 200-day moving average was $3.63 The short ratio stood at 3.93 indicating a short percent outstanding of 0%.

Around 782% of the company’s stock are held by insiders while 4022% are held by institutions.